ACCESSION: MSBNK-SMB_Measured-HSA001P0232002
RECORD_TITLE: Characterized; Isobutyryl-L-carnitine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.03.04 (Averaged 2025.02.14, Processed 2025.02.14, Annotated 2025.02.21, Curated 2025.03.04)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 11
COMMENT: RAW_SPEC {'17_posi_2885': {'bp': 883725.0, 'sum': 1457611.0}, '16_posi_2876': {'bp': 784442.0, 'sum': 1337534.0}, '8_posi_2841': {'bp': 738752.0, 'sum': 1232759.0}, '5_posi_2821': {'bp': 708505.0, 'sum': 1225871.0}, '12_posi_2855': {'bp': 674167.0, 'sum': 1154180.0}, '4_posi_2831': {'bp': 660366.0, 'sum': 1201330.0}, '3_posi_2802': {'bp': 649474.0, 'sum': 1126247.0}, '19_posi_2978': {'bp': 646751.0, 'sum': 1121670.0}, '16_posi_2738': {'bp': 619193.0, 'sum': 1025183.0}, '14_posi_2750': {'bp': 569248.0, 'sum': 957598.0}, '8_posi_2750': {'bp': 476221.0, 'sum': 800319.0}}
COMMENT: RETENTION_TIME_STDEV 0.141
COMMENT: PRECURSOR_M/Z_RAW 232.153892
COMMENT: PRECURSOR_M/Z_STDEV 0.000045
COMMENT: PRECURSOR_IN_MS1 mz 232.154325; int 5.119; delta(ppm) 1.203629
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.035; C11H21NO4; [M+H]+; delta(ppm) -0.034610
COMMENT: PROPOSED_MF MS-FINDER 3.821; C11H21NO4; [M+H]+; delta(ppm) -0.037032
COMMENT: PROPOSED_MF SIRIUS5_Sirius 3.425; C11H21NO4; [M+H]+; delta(ppm) -0.037032
COMMENT: PROPOSED_MF SIRIUS5_Sirius 0.423; C12H17N5; [M+H]+; delta(ppm) -5.797882
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.999; C11H21NO4; [M+H]+; delta(ppm) -0.037032
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.001; C12H17N5; [M+H]+; delta(ppm) -5.797882
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.635; C11H21NO4; [M+H]+; delta(ppm) -0.037032
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.536; C12H17N5; [M+H]+; delta(ppm) -5.797882
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.133; C9H19N4O3; [M+H]+; delta(ppm) 5.746497
COMMENT: PROPOSED_MF SIRIUS6_Sirius -9.326; C8H20N6P; [M+H]+; delta(ppm) -7.129320
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C11H21NO4; [M+H]+; delta(ppm) -0.037032
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; QWYFHHGCZUCMBN-SECBINFHSA-N; C11H21NO4; Butyrylcarnitine - 20.00 eV
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.988; QWYFHHGCZUCMBN-UHFFFAOYNA-N; [M+H]+; CCCC(=O)OC(CC([O-])=O)C[N+](C)(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.500; LRCNOZRCYBNMEP-UHFFFAOYNA-N; [M+H]+; CC(C)C(=O)OC(CC([O-])=O)C[N+](C)(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.486; YLMYYIWAVZBXQC-UHFFFAOYSA-N; [M+H]+; OCC1CC(NC2CCOCC2)C(O)C1O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.417; DEOXZKRLUAPGRF-PUHCEXAONA-N; [M+H]+; CO[C@@H]1C[C@@H](OC)[C@@H]([C@@H](C)O1)N(C)C(C)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.403; FRCXAIAZVUGTJG-UHFFFAOYSA-N; [M+H]+; O=C(NC1CC(COC)C(O)C1O)C(C)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.705; QWYFHHGCZUCMBN-UHFFFAOYNA-N; [M+H]+; Butyrylcarnitine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.538; LRCNOZRCYBNMEP-UHFFFAOYNA-N; [M+H]+; Isobutyryl-L-carnitine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.986; ULASHFIVFAPWLV-IMWMWJONNA-N; [M+H]+; UNPD48043
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.787; MDXGYYOJGPFFJL-QMMMGPOBSA-N; [M+H]+; N(alpha)-t-butoxycarbonyl-L-leucine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.784; BSMXBPUTGXWAGA-UHFFFAOYSA-N; [M+H]+; 2-{[(tert-butoxy)carbonyl](methyl)amino}pentanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.784; XPUAXAVJMJDPDH-UHFFFAOYSA-N; [M+H]+; 2-{[(tert-butoxy)carbonyl](methyl)amino}-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.738; DEOXZKRLUAPGRF-PUHCEXAONA-N; [M+H]+; UNPD135877
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.735; QJCNLJWUIOIMMF-UHFFFAOYSA-N; [M+H]+; 2-{[(tert-butoxy)carbonyl]amino}-3-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.715; ZIOCIQJXEKFHJO-UHFFFAOYSA-N; [M+H]+; 2-{[(tert-butoxy)carbonyl]amino}hexanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.698; DYTVYDVNJBXBMW-UHFFFAOYSA-N; [M+H]+; methyl 2-(2-hydroxy-3-methylbutanamido)-3-methylbutanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.686; RVOWFRGAKGPNMK-VIFPVBQESA-N; [M+H]+; N-heptanoyl-L-homoserine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.678; SWEPQJJUAVEABL-UHFFFAOYSA-N; [M+H]+; 2-(2-hydroxy-3-methylbutanamido)-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.670; LRFZIPCTFBPFLX-UHFFFAOYNA-N; [M+H]+; (S)-2-((tert-Butoxycarbonyl)amino)-3,3-dimethylbutanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.664; ZYPZGYMHUVJCDT-UHFFFAOYSA-N; [M+H]+; (1-hydroxy-2,2,5,5-tetramethylpyrrolidin-3-yl)oxymethyl acetate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.658; CYQNLOGQMXTRSY-UHFFFAOYSA-N; [M+H]+; 6-aminoundecanedioic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.643; NHQUUILSXUJSSP-RKDXNWHRSA-N; [M+H]+; 3-(1-Aminoethyl)Nonanedioic Acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.637; YLMYYIWAVZBXQC-UHFFFAOYSA-N; [M+H]+; 3-(hydroxymethyl)-5-[(oxan-4-yl)amino]cyclopentane-1,2-diol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.632; ZDKFMHKWZATBMR-UHFFFAOYSA-N; [M+H]+; tert-butyl [(tert-butoxycarbonyl)amino]acetate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.618; FRCXAIAZVUGTJG-UHFFFAOYSA-N; [M+H]+; N-[2,3-dihydroxy-4-(methoxymethyl)cyclopentyl]-2-methylpropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; LRCNOZRCYBNMEP-UHFFFAOYNA-N; [M+H]+; Isobutyryl-L-carnitine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; QWYFHHGCZUCMBN-UHFFFAOYNA-N; [M+H]+; Butyrylcarnitine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.194; ULASHFIVFAPWLV-IMWMWJONNA-N; [M+H]+; UNPD48043
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.190; NHQUUILSXUJSSP-RKDXNWHRSA-N; [M+H]+; 3-(1-Aminoethyl)Nonanedioic Acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.165; BSMXBPUTGXWAGA-UHFFFAOYSA-N; [M+H]+; 2-{[(tert-butoxy)carbonyl](methyl)amino}pentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.165; QJCNLJWUIOIMMF-UHFFFAOYSA-N; [M+H]+; 2-{[(tert-butoxy)carbonyl]amino}-3-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.165; XPUAXAVJMJDPDH-UHFFFAOYSA-N; [M+H]+; 2-{[(tert-butoxy)carbonyl](methyl)amino}-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.165; ZIOCIQJXEKFHJO-UHFFFAOYSA-N; [M+H]+; 2-{[(tert-butoxy)carbonyl]amino}hexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.164; RVOWFRGAKGPNMK-VIFPVBQESA-N; [M+H]+; N-heptanoyl-L-homoserine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.161; ZDKFMHKWZATBMR-UHFFFAOYSA-N; [M+H]+; tert-butyl [(tert-butoxycarbonyl)amino]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.135; MDXGYYOJGPFFJL-QMMMGPOBSA-N; [M+H]+; N(alpha)-t-butoxycarbonyl-L-leucine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.135; LRFZIPCTFBPFLX-UHFFFAOYNA-N; [M+H]+; (S)-2-((tert-Butoxycarbonyl)amino)-3,3-dimethylbutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.135; DYTVYDVNJBXBMW-UHFFFAOYSA-N; [M+H]+; methyl 2-(2-hydroxy-3-methylbutanamido)-3-methylbutanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.135; SWEPQJJUAVEABL-UHFFFAOYSA-N; [M+H]+; 2-(2-hydroxy-3-methylbutanamido)-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.132; FRCXAIAZVUGTJG-UHFFFAOYSA-N; [M+H]+; N-[2,3-dihydroxy-4-(methoxymethyl)cyclopentyl]-2-methylpropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.132; YLMYYIWAVZBXQC-UHFFFAOYSA-N; [M+H]+; 3-(hydroxymethyl)-5-[(oxan-4-yl)amino]cyclopentane-1,2-diol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.130; DEOXZKRLUAPGRF-PUHCEXAONA-N; [M+H]+; UNPD135877
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.118; ZYPZGYMHUVJCDT-UHFFFAOYSA-N; [M+H]+; (1-hydroxy-2,2,5,5-tetramethylpyrrolidin-3-yl)oxymethyl acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.029; CYQNLOGQMXTRSY-UHFFFAOYSA-N; [M+H]+; 6-aminoundecanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.144; MDXGYYOJGPFFJL-QMMMGPOBSA-N; [M+H]+; (2S)-4-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.626; QJCNLJWUIOIMMF-YUMQZZPRSA-N; [M+H]+; (2S,3S)-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.503; XTTIXKIEKDPSIJ-UHFFFAOYSA-N; [M+H]+; diethyl 2-[2-(dimethylamino)ethyl]propanedioate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.337; ZIOCIQJXEKFHJO-UHFFFAOYSA-N; [M+H]+; 2-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.281; XPUAXAVJMJDPDH-QMMMGPOBSA-N; [M+H]+; (2S)-3-methyl-2-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.096; LRFZIPCTFBPFLX-SSDOTTSWSA-N; [M+H]+; (2S)-3,3-dimethyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.080; QDLPAHLHHBCWOW-UHFFFAOYSA-N; [M+H]+; 2-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethoxy]ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; VEDNSEZGQMNNER-UHFFFAOYSA-N; [M+H]+; 9-(2-hydroxyethylamino)-9-oxononanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.963; RUFDYIJGNPVTAY-UHFFFAOYSA-N; [M+H]+; 6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.717; DWFOEHLGMZJBAA-QMMMGPOBSA-N; [M+H]+; tert-butyl (4S)-4-(hydroxymethyl)-2,2-dimethyl-1,3-oxazolidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.712; KKIAMBQPKZBCIZ-UHFFFAOYSA-N; [M+H]+; 3-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-ylamino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.711; OXZUPKSEIKZASL-UHFFFAOYSA-N; [M+H]+; ethyl 3-[(3-ethoxy-3-oxopropyl)-methylamino]propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.711; HJFHLUQGWPTHMM-UHFFFAOYSA-N; [M+H]+; 2-[(2-methylpropan-2-yl)oxycarbonyl-propylamino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.699; ZYVBYRKLECISLP-DTWKUNHWSA-N; [M+H]+; tert-butyl (2S,4R)-2-(hydroxymethyl)-4-methoxypyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.692; VUDVZUAUPOAVLM-UHFFFAOYSA-N; [M+H]+; tert-butyl 2-(2-hydroxyethyl)morpholine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.691; BYPQXUYSPTXBGE-UHFFFAOYSA-N; [M+H]+; 2-ethyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.690; ZDKFMHKWZATBMR-UHFFFAOYSA-N; [M+H]+; tert-butyl 2-[(2-methylpropan-2-yl)oxycarbonylamino]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.687; MFKIFVQJZNMZJB-UHFFFAOYSA-N; [M+H]+; 3,3-dimethyl-4-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.685; SLJSFXUOECCLPA-UHFFFAOYSA-N; [M+H]+; tert-butyl 6-(hydroxymethyl)-1,4-oxazepane-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.684; TWMVVJUXUMIAAJ-UHFFFAOYSA-N; [M+H]+; 2,2-dimethyl-4-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.683; HPDNHXHMUBENMG-UHFFFAOYSA-N; [M+H]+; 2-[(2-methylpropan-2-yl)oxycarbonyl-(2-methylpropyl)amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.679; IGJIQZVMCRTQQX-UHFFFAOYSA-N; [M+H]+; 3-methyl-2-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.679; ISQYKHGGGYDEKA-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-(2-hydroxyethyl)morpholine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.679; HEFYZXCUGNIOCW-DTORHVGOSA-N; [M+H]+; tert-butyl (3R,4S)-3,4-bis(hydroxymethyl)pyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.678; JFAPXRSEKIGSOM-MRVPVSSYSA-N; [M+H]+; ethyl (2R)-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.678; XXRZYWCOLXWUBH-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-(hydroxymethyl)-3-methoxypyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.678; BDRCIETWVHQBHF-UHFFFAOYSA-N; [M+H]+; 2-ethyl-4-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.678; OJACPWBUNQMKCF-UHFFFAOYSA-N; [M+H]+; tert-butyl 2,2-bis(hydroxymethyl)pyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.677; WTYLEXCGLNFFIN-QMMMGPOBSA-N; [M+H]+; (3S)-3-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.677; DXNVPQDZAGYXEH-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-(hydroxymethyl)-3-methylmorpholine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.677; NWWBTHVRHUCSND-QMMMGPOBSA-N; [M+H]+; (4S)-4-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.677; VWVWYFVYZSIVFW-RKDXNWHRSA-N; [M+H]+; tert-butyl (2R,4R)-4-hydroxy-2-(hydroxymethyl)piperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.677; UTZHJRIZVJUPBJ-UHFFFAOYSA-N; [M+H]+; methyl 2-methyl-3-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.677; SEUXPDHPZUFZFQ-UHFFFAOYSA-N; [M+H]+; 2-methyl-2-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.677; DIVFMRKFZNRXMB-UHFFFAOYSA-N; [M+H]+; tert-butyl 4-hydroxy-2-(hydroxymethyl)-2-methylpyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.672; LUXMZCJCTUATDM-MRVPVSSYSA-N; [M+H]+; (3R)-4-methyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.649; MXPBQQXWXZWBMK-UHFFFAOYSA-N; [M+H]+; 2,3-dimethyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.648; QNPYJTQBCNHGDM-UHFFFAOYSA-N; [M+H]+; tert-butyl N-[4-(hydroxymethyl)oxan-4-yl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.644; JZICKPKNTMWZSX-UHFFFAOYSA-N; [M+H]+; tert-butyl N-[3-hydroxy-1-(hydroxymethyl)cyclopentyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.644; NFMLOTGNJNBRPQ-UHFFFAOYSA-N; [M+H]+; 4-methyl-4-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.644; MPDQVMSQLKWPHZ-UHFFFAOYSA-N; [M+H]+; tert-butyl N-[2-hydroxy-1-(oxolan-3-yl)ethyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.644; WCFHGXORJJFHPK-UHFFFAOYSA-N; [M+H]+; tert-butyl N-[[4-(hydroxymethyl)oxolan-2-yl]methyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.644; UFHWXFDYSQKGMY-UHFFFAOYSA-N; [M+H]+; tert-butyl N-[1-(1,2-dihydroxyethyl)cyclobutyl]carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; CPQILPVJBOJVJC-UHFFFAOYSA-N; [M+H]+; N-[4-hydroxy-3,3-bis(hydroxymethyl)-2-methylpentan-2-yl]prop-2-enamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -14.608; QWYFHHGCZUCMBN; [M+H]+; Butyrylcarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -40.504; LRCNOZRCYBNMEP; [M+H]+; Isobutyryl-carnitine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -222.146; XTTIXKIEKDPSIJ; [M+H]+; diethyl[2-(dimethylamino)ethyl]propanedioate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -275.918; ZDKFMHKWZATBMR; [M+H]+; Boc-glycine tert-butyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -276.096; OXZUPKSEIKZASL; [M+H]+; Di-|A-carbethoxyethyl-d8-methylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -303.482; MUGTWUTYHDGLJE; [M+H]+; Methyl N-(isopropyl)-N-(3-methoxy-3-oxopropyl)-beta-alaninate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -303.731; NHQUUILSXUJSSP; [M+H]+; (3S)-3-[(1S)-1-aminoethyl]nonanedioic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -315.020; CYQNLOGQMXTRSY; [M+H]+; 6-ammonioundecanedioate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -327.358; ULASHFIVFAPWLV; [M+H]+; diethyl 2-aminoheptanedioate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -332.052; RUFDYIJGNPVTAY; [M+H]+; AmbotzBAA1336
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -339.049; HPDNHXHMUBENMG; [M+H]+; 2-{[(tert-butoxy)carbonyl](2-methylpropyl)amino}acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -348.869; MDXGYYOJGPFFJL; [M+H]+; AmbotzBAA1101
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -349.619; BDRCIETWVHQBHF; [M+H]+; (2R)-2-ethyl-4-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -367.757; KKIAMBQPKZBCIZ; [M+H]+; N-Boc-3-isopropylamino-propionic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -368.057; IGJIQZVMCRTQQX; [M+H]+; 2-Isopropyl-3-(Boc amino)propionic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -370.671; ZIOCIQJXEKFHJO; [M+H]+; AmbotzBAA1284
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -386.187; LRFZIPCTFBPFLX; [M+H]+; zlchem 261
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -393.927; QJCNLJWUIOIMMF; [M+H]+; Boc-allo-Ile-OH
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -396.891; BSMXBPUTGXWAGA; [M+H]+; Boc-N-methyl-D-norvaline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -404.992; RVOWFRGAKGPNMK; [M+H]+; 2-(heptanoylamino)-4-hydroxybutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -406.570; HJQMYHUTXHUJNS; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -422.146; SLJSFXUOECCLPA; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -424.198; XPUAXAVJMJDPDH; [M+H]+; AmbotzBAA1272
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -429.528; SWEPQJJUAVEABL; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -431.101; DYTVYDVNJBXBMW; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -436.859; ZYVBYRKLECISLP; [M+H]+; tert-butyl (2S,4R)-2-(hydroxymethyl)-4-methoxypyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -481.357; FRCXAIAZVUGTJG; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -483.025; DEOXZKRLUAPGRF; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -509.939; YLMYYIWAVZBXQC; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.661; QWYFHHGCZUCMBN; [M+H]+; Butyrylcarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -43.849; LRCNOZRCYBNMEP; [M+H]+; Isobutyrylcarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -70.398; QWYFHHGCZUCMBN; [M+H]+; 3-Butanoyloxy-2,2,3-trideuterio-4-(trimethylazaniumyl)butanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -182.552; OLQVCCWGONSOAD; [M+H]+; d3-Butyrylcarnitine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -269.306; MFKIFVQJZNMZJB; [M+H]+; Boc-4-amino-3,3-dimethyl-butyric acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -270.512; QDLPAHLHHBCWOW; [M+H]+; Propargyl-PEG4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -327.280; ZDKFMHKWZATBMR; [M+H]+; Boc-Gly-OtBu
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -329.465; HPDNHXHMUBENMG; [M+H]+; 2-{[(Tert-butoxy)carbonyl](2-methylpropyl)amino}acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -332.099; XTTIXKIEKDPSIJ; [M+H]+; Diethyl[2-(dimethylamino)ethyl]propanedioate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -348.669; TWMVVJUXUMIAAJ; [M+H]+; 4-Boc-amino-2,2-dimethylbutyric acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -352.879; OXZUPKSEIKZASL; [M+H]+; Di-beta-carbethoxyethyl-d8-methylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.942; LRCNOZRCYBNMEP; [M+H]+; Isobutyrylcarnitine
COMMENT: CONFIDENCE Level 3: Tentative candidate, Isobutyryl-L-carnitine, LRCNOZRCYBNMEP-UHFFFAOYNA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (5); This structural isomer was suggested from the biological context HMDB HMDB0000736;HMDB0062556;HMDB0062606;
CH$NAME: Isobutyryl-L-carnitine
CH$NAME: (3R)-3-(2-methylpropanoyloxy)-4-(trimethylazaniumyl)butanoate
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C11H21NO4
CH$EXACT_MASS: 231.147058
CH$SMILES: CC(C)C(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C
CH$IUPAC: InChI=1S/C11H21NO4/c1-8(2)11(15)16-9(6-10(13)14)7-12(3,4)5/h8-9H,6-7H2,1-5H3/t9-/m1/s1
CH$LINK: CHEBI CHEBI:73017
CH$LINK: HMDB HMDB0000736
CH$LINK: INCHIKEY LRCNOZRCYBNMEP-SECBINFHSA-N
CH$LINK: LIPIDMAPS LMFA07070075
CH$LINK: PUBCHEM CID:168379
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 5.669
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 232.154326
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-001i-2190000000-bcf741cbeb923cd8be26
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  60.0808742 47.7941 60.081514 0.9987 4.59 0.8455 11 f{C3H10N1}/1.64ppm,p-C8H12O4
  85.0284102 265.7089 85.028890 0.2587 13.72 0.8636 11 f{C4H5O2}/0.05ppm,p-C7H17N1O2
  144.1019073 9.7920 144.101809 2.5607 2.60 -0.2833 9 f{C7H14N1O2}/0.02ppm,p-C4H8O2
  173.0808879 195.0193 173.080771 0.3582 11.00 0.9273 11 f{C8H13O4}/0.30ppm,p-C3H9N1
  214.1544990 9.9154 214.154356 2.0266 2.37 -0.0238 8 ?
  214.2026909 48.8249 214.202548 1.2838 14.02 0.6273 11 ?
  215.0913312 9.8189 215.091188 2.4827 3.43 0.2485 10 ?
  232.1542301 999.0000 232.154076 0.3101 0.00 1.0000 11 f{C11H22N1O4}/-0.45ppm,p
  232.2127182 50.3290 232.212565 2.7949 14.21 0.5818 11 ?
PK$NUM_PEAK: 9
PK$PEAK: m/z int. rel.int.
  60.080874 47.79 47
  85.028410 265.71 265
  144.101907 9.79 9
  173.080888 195.02 195
  214.154499 9.92 9
  214.202691 48.82 48
  215.091331 9.82 9
  232.154230 999.00 999
  232.212718 50.33 50
//
